What is NDC 31722-547?

31722-547 is the product NDC for Topiramate, Topiramate 25 mg/1 capsule, extended release, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Topiramate?

278 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Topiramate NDC 31722-547 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-547Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0547Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-547-30	31722054730	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-547-30)Marketed from Apr 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Topiramate
Generic name (nonproprietary): topiramate
Active ingredients: Topiramate — 25 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217443
Marketing start: Apr 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 31722-547_c4f0c0d0-430f-4c9d-96f0-8c90f6af31e8SPL ID c4f0c0d0-430f-4c9d-96f0-8c90f6af31e8SPL set ID dbc52b16-b93d-4d83-942b-485c502db1faRxCUI 1436239, 1437278, 1437283, 1437288UNII 0H73WJJ391UPC 0331722548304, 0331722547307, 0331722550307, 0331722549301

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722054730 followed by a unit qualifier and the quantity

Package 31722-0547-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topiramate extended-release capsules are indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older (1.1); adjunctive therapy for the treatment of partial-onset, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome (LGS) in patients 6 years of age and older (1.2) Preventive treatment of migraine in patients 12 years of age and older (1.3) 1.1 Monotherapy Epilepsy Topiramate extended-release capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-547

What is NDC 31722-547?: 31722-547 is the product NDC for Topiramate, Topiramate 25 mg/1 capsule, extended release, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Topiramate.
What is the active ingredient?: Topiramate.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Topiramate?: 278 other product NDCs are listed under this name. See all Topiramate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Topiramate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-952	60760-0952-60
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0357	67046-0357-03
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1691	67046-1691-03
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-079	87441-0079-01
Topiramate	Topiramate 100 mg/1	TabletOral	Coupler LLC	67046-1688	67046-1688-03
topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0375	67046-0375-03
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	AvPAK	50268-808	50268-0808-15
topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	AvPAK	50268-806	50268-0806-15
topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	AvPAK	50268-807	50268-0807-15
topiramate	Topiramate 200 mg/1	Tablet, Film coatedOral	AvPAK	50268-809	50268-0809-15

All 279 Topiramate NDCs

Other NDCs under ANDA 217443

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217443
Product	Strength	Form · route	Labeler	Product NDC
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-548
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-549
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-550